Where to Inject Tirzepatide: Best Sites and How to Inject


Published November 7, 202611 min read

Pricing is accurate as of November 2026 and subject to change.


Key Takeaways

  • The Zepbound and Mounjaro labels (revised August 2026) list three injection sites: the stomach (abdomen), the thigh, and the back of the upper arm, which another person should inject.
  • In the stomach, stay at least 2 inches from the belly button, as the KwikPen instructions say.
  • No site has been shown to work better. In Lilly's injection-site study, total exposure after thigh and upper arm injections was 95% and 99% of the abdomen, and the label calls it similar.
  • Use a new spot every week; the label says rotating lowers the risk of pits, thickened skin and lumps at injection sites.
  • Compounded vials often differ in concentration, so the units you draw come from your own vial's label; the FDA said in August 2026 that volumes are not interchangeable.
  • In the Zepbound trials, injection site reactions occurred in 6% to 8% of people taking Zepbound, compared with 2% on placebo.
MaxLife header: where to inject tirzepatide, stomach, thigh or upper arm, with injection supplies on a tray

Where to inject tirzepatide: under the skin of your stomach (abdomen) or thigh, or the back of your upper arm if another person gives the injection. Those are the three sites in the Zepbound prescribing information and the Mounjaro prescribing information, both revised in August 2026. In the stomach, stay at least 2 inches from your belly button, and use a different spot every week. No site has been shown to work better: the label says tirzepatide reaches "similar exposure" in the abdomen, thigh and upper arm.

This guide covers each injection site, what Eli Lilly's own injection-site study found, how to rotate, step-by-step basics for pens and vials, what to know about compounded vials and units, and which skin reactions are normal.

Compounded tirzepatide is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. The same three injection sites are used for compounded tirzepatide, but your pharmacy's label and instructions apply to your vial.

Where Can You Inject Tirzepatide?

You can inject tirzepatide into the fatty layer under the skin (a subcutaneous injection) in three areas: the abdomen, the thigh and the back of the upper arm. The label says: "Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose." It also says not to inject it into a muscle or a vein.

SiteWho can injectLabel notes
Stomach (abdomen)You or another personAt least 2 inches from the belly button
ThighYou or another personThe front of the thigh
Back of the upper armAnother personNot a self-injection site in the instructions

Whichever area you choose, pick skin that is healthy. The instructions say not to inject "where the skin has pits, is thickened, or has lumps," or "where the skin is tender, bruised, scaly or hard, or into scars or damaged skin." The pen instructions add that "Your healthcare provider can help you choose the injection site that is best for you."

Where to inject tirzepatide in the stomach

Inject anywhere on the stomach area where you can reach soft, healthy skin, at least 2 inches (about 5 cm) from your belly button. The 2-inch rule appears in the instructions for the Zepbound and Mounjaro KwikPens, and the Wegovy pen instructions give the same distance. The stomach is easy to see and reach on your own.

Where to inject tirzepatide in the thigh

Inject into the front of your thigh. The Zepbound instructions say "thigh" and illustrate the sites with a front and a back view of the body, and the Wegovy pen instructions describe the area as the "upper leg (front of the thighs)." Like the stomach, the thigh is a site you can use by yourself, and it's a good second area for rotating.

Can you inject tirzepatide in your arm?

Yes, but the label says another person should give the injection in the back of the upper arm. If you live alone, use your stomach and thighs. The Zepbound instructions don't list the arm as a site to inject by yourself.

What Is the Best Place to Inject Tirzepatide for Best Results?

There is no best place to inject tirzepatide for weight loss; the right site is the one you can use correctly every week. The label's clinical pharmacology section says: "Similar exposure was achieved with subcutaneous administration of tirzepatide in the abdomen, thigh, or upper arm." Exposure means how much medicine reaches your bloodstream over time.

That sentence rests on a study Eli Lilly ran in 2019 and 2020, registered as NCT04050670. In it, 54 healthy adults with a wide range of body sizes each received a single 5 mg dose of tirzepatide in the abdomen, the thigh and the upper arm, at separate times. The results:

Injection siteTotal exposure, compared with the abdomenPeak level, compared with the abdomen
Upper arm99%92%
Thigh95%86%

The total amount of tirzepatide in the blood was nearly the same at all three sites. The peak was somewhat lower after arm and thigh injections. For context, the label says tirzepatide reaches its peak level a median of 24 hours after an injection (range 8 to 72 hours) and has a half-life of about 5 to 6 days in people with overweight or obesity, which is why one injection a week is enough.

Two limits are worth knowing. This was a study of blood levels after one dose in healthy volunteers, not a weight-loss trial. And we found no study that compares weight loss by injection site. What the label does specify is how to use the medicine: once a week, at the prescribed dose, with a reduced-calorie diet and more physical activity. If you're getting compounded tirzepatide through MaxLife, our pharmacy instructions include injection steps from the partner pharmacies that publish them; otherwise, follow the instructions that came with your vial.

The study also recorded side effects at each site. After the single 5 mg dose, nausea was reported after 37% of stomach injections, 22% of upper arm injections and 21% of thigh injections (20 of 54, 12 of 54 and 11 of 53 people), according to the study results. The study was small and open label and wasn't designed to compare side effects, and the label doesn't favor one site. If nausea bothers you, ask your provider whether switching sites is worth a try.

Is it better to inject tirzepatide in the stomach or thigh?

Neither is better for results. The study's total exposure was within about 5% between the two sites, which the label calls similar. Choose based on comfort and reach, and rotate between both areas if you like.

Where to Inject Zepbound and Mounjaro

Zepbound injection sites and Mounjaro injection sites are the same three areas, because both medicines are tirzepatide made by Eli Lilly. Inject into the stomach or thigh yourself, or have someone else inject into the back of your upper arm, and use a new spot each week. Lilly's Zepbound how-to page gives the same advice.

One difference applies to Mounjaro, which is approved for type 2 diabetes and may be used with insulin. The Mounjaro label says to give insulin and Mounjaro "as separate injections and never mix," and that "It is acceptable to inject MOUNJARO and insulin in the same body region, but the injections should not be adjacent to each other." The Zepbound instructions also say not to inject it "in the same injection site used for other medicines." For how the two brands differ in approval, dosing and cost, see Zepbound vs Mounjaro.

Semaglutide (Wegovy and Ozempic) uses the abdomen, thigh and upper arm too, and its labels likewise say exposure is similar at the three sites. Doses and units are in our semaglutide dosage chart.

How Often Should You Rotate Tirzepatide Injection Sites?

Change your injection spot every week. The label says: "You may use the same area of your body but be sure to choose a different injection site in that area. Do not use the same site for each injection."

Rotation protects your skin. The vial instructions say to rotate "to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites." Skin that has already changed this way shouldn't be used for injections.

A simple way to rotate is to divide your sites into zones and move through them in order, for example:

  1. Week 1: left side of the stomach
  2. Week 2: right side of the stomach
  3. Week 3: left thigh
  4. Week 4: right thigh

Then start again, using a slightly different spot within each zone. A note on your phone or calendar with the date and the spot makes it easy to remember. This pattern is only an example; your provider may suggest a different one.

How to Inject Tirzepatide

How you inject tirzepatide depends on the device: a single-dose pen, a 4-dose KwikPen or a vial with a syringe. Read the Instructions for Use that came with your product each time you get a refill, because they can change. The Medication Guide says your healthcare provider should show you how before your first injection.

Before every injection:

  • Check the label for the right medicine and dose, and make sure it hasn't expired.
  • Check the medicine. Brand tirzepatide should be clear and colorless to slightly yellow, not frozen, not cloudy and without particles. Compounded tirzepatide should look the way its pharmacy label describes.
  • Wash your hands.
  • No need to warm it. The Zepbound pen instructions say "It is not necessary to warm the pen to room temperature."

If the medicine was frozen, left somewhere hot or arrived warm, don't use it. Our guide on whether tirzepatide goes bad explains the storage limits for each product.

How to inject Zepbound with the single-dose pen

The single-dose pen has a hidden needle and gives the whole dose for you. Pull off the gray base cap, place the clear base flat on your skin at the injection site, and unlock the pen. Press and hold the purple button for up to 10 seconds. The first click means the injection has started and the second click means it's done; the gray plunger is then visible. If a drop of liquid or blood appears on your skin, press a cotton ball or gauze on it. Don't rub the site.

With the Zepbound KwikPen

The KwikPen holds 4 weekly doses and uses a separate pen needle. The instructions say to "Always use a new pen needle for each injection" and to prime the pen before each weekly injection. Turn the dose knob all the way, insert the needle, push the knob in and slowly count to 5 before you remove it. If you aren't sure you got the full dose, the instructions say "do not start over or repeat the injection"; call your provider or Lilly. Never share a KwikPen, even with a new needle, and don't transfer medicine from the pen into a syringe.

With a vial and syringe (Zepbound vials and compounded vials)

Vials need a new syringe and needle for every injection. The Zepbound vial instructions follow these steps:

  1. Wipe the rubber stopper with an alcohol swab.
  2. Use a new syringe and needle. The label gives the example of "a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose" for Zepbound vials.
  3. Draw air into the syringe, push it into the vial, then turn the vial upside down and draw your dose. Tap out air bubbles.
  4. Insert the needle into the skin at your chosen site. Your provider should tell you whether to pinch the skin first.
  5. Push the plunger, and keep the needle in your skin for at least 5 seconds so you get the full dose.
  6. Don't recap the needle. Put it straight into a sharps container.

Zepbound single-dose vials hold one 0.5 mL dose, and the 4-dose vials give 0.6 mL per weekly dose. A compounded vial is different: the amount you draw depends on its concentration, so follow the volume or units on your pharmacy label. The FDA advises using a new, sterile needle and syringe for each dose and throwing away a multi-dose vial within 28 days after first use, even if medicine is left.

How many units of compounded tirzepatide should you inject?

The number of units depends on the concentration printed on your vial, so the only right answer is the one on your prescription label or from your pharmacy. In an August 12, 2026 letter to state medical boards, the FDA said compounded drugs "often have different concentrations than FDA approved products" and that, as a result, "the volumes are not interchangeable between the two." A units figure from a friend's vial, an online chart or a previous pharmacy can be wrong for yours.

Insulin syringes are marked in units. On a standard U-100 (1 mL) syringe, 100 units equals 1 mL, so a 5-unit mark is 0.05 mL. In a 2024 alert, the FDA described patients who drew 5 to 20 times their intended dose of compounded semaglutide from multi-dose vials, partly from confusion between milligrams, milliliters and units. Our tirzepatide dosage chart explains how concentration changes the units, and the dosage calculator shows the math for a label. Neither replaces your pharmacy's instructions, and every dose change belongs to your prescriber.

Getting Help With Your Injections

The easiest way to inject correctly is to have instructions for your exact product and someone to ask. MaxLife is a telehealth patient management platform, not a pharmacy. You complete an online intake that takes about 2 minutes, and an independent licensed provider reviews it, usually within 24 hours, and decides whether a prescription is right for you. If it is, a licensed partner pharmacy prepares and dispenses your compounded tirzepatide, with the supplies you need and free expedited shipping.

After it arrives, check the pharmacy medication instructions tool: where your pharmacy has a guide, it shows injection steps, a units table for that pharmacy's concentration, storage tips and who to call. Otherwise, follow the instructions that came with your vial. You can also ask for a video visit, and plans include your provider's follow-up.

Compounded tirzepatide through MaxLife costs $120 a month, flat: all-inclusive and the same price at every dose, with no membership fee. See what tirzepatide costs with and without insurance. If your insurance covers Zepbound or Mounjaro, the FDA-approved brand may be the better choice for you. Compounded medicines are not FDA-approved, and the results of the Zepbound trials have not been shown for compounded tirzepatide.

What Should You Avoid When Injecting Tirzepatide?

The instructions warn against a handful of habits. Avoid these:

  • Injecting into a muscle or vein. Tirzepatide is for injection under the skin only.
  • Using the same spot every week. Rotate within an area to protect your skin.
  • Injecting into damaged skin: pits, lumps, thickened, tender, bruised, scaly or hard skin, or scars.
  • Mixing it with other medicines or injecting it where you inject other medicines.
  • Reusing or sharing needles and syringes. Use a new one every time, and never share a pen, even with a new needle.
  • Rubbing the site after the injection.
  • Repeating a dose you think didn't go in fully. Call your provider or pharmacist first.
  • Guessing your units from another vial, an online chart or an old label.
  • Injecting medicine that looks wrong: cloudy, discolored, with particles, or frozen.

If you inject too much, the label says to call your healthcare provider or Poison Help at 1-800-222-1222, or go to the nearest emergency room right away.

Is It Normal to Have a Reaction Where You Inject?

Mild redness, itching, bruising or tenderness where you inject is a known side effect. In two placebo-controlled Zepbound weight-loss trials lasting up to 72 weeks, injection site reactions happened in 6% to 8% of people taking Zepbound, depending on the dose, compared with 2% taking a placebo, according to the label. They included bruising, redness, itching, pain and rash at the site. The label also notes these reactions were more common in people who developed antibodies to tirzepatide (11.3% versus 1%).

Rotating sites and injecting only into healthy skin follow the label's advice for protecting your skin. Tell your provider if a reaction is spreading, getting worse or not going away, or if you find lumps or pits where you inject.

Get medical help right away if you have signs of a serious allergic reaction, which the Medication Guide lists as swelling of your face, lips, tongue or throat; problems breathing or swallowing; a severe rash or itching; fainting or feeling dizzy; or a very rapid heartbeat.

How to Throw Away Needles, Syringes and Pens

Put used needles, syringes and single-dose pens in an FDA-cleared sharps disposal container right away, the instructions say. If you don't have one, you can use a heavy-duty plastic household container with a tight, puncture-resistant lid that stays upright and doesn't leak, labeled as hazardous waste. When it's almost full, follow your community's rules for disposal; the FDA's safe sharps disposal page lists the options by state. Don't recycle the container, and don't put loose needles in the trash.

Frequently Asked Questions

The label lists three sites: the stomach (abdomen), the thigh, and the back of the upper arm, which another person should inject. No site has been shown to work better, so the best one is the site you can reach and use correctly every week. In the stomach, stay at least 2 inches from your belly button.
Not for how much medicine you absorb. The Zepbound label says similar exposure was achieved in the abdomen, thigh and upper arm, and in Lilly's injection-site study total exposure was within about 5% across the three sites. What matters more is injecting under the skin, into healthy skin, and rotating every week. In the same study, nausea was reported less often after thigh and arm injections than after stomach injections, but that was one small single-dose study.
No site has been shown to hurt less. In Lilly's injection-site study, no injection-site reaction was reported often enough to be listed (5% or more of people) at any of the three sites. Use a new spot each week and skip skin that is tender, bruised or scarred.
Ask your provider. The Zepbound vial instructions say your healthcare provider should tell you whether to pinch the skin before injecting. The single-dose pen instructions say to place the pen's clear base flat against your skin and don't mention pinching.
No. You can use the same area, such as your stomach, but choose a different spot within it each week. The label says rotating lowers the risk of pits, thickened skin and lumps at injection sites.
The label says another person should give the injection in the back of the upper arm. If you inject by yourself, use your stomach or thighs, which the instructions list as self-injection sites.
Tirzepatide is meant to go under the skin, and the label says not to inject it into a muscle or a vein. If you think a dose went into a muscle, don't take another dose on your own. Call your provider or pharmacist for advice.
It depends on the concentration of your vial, so use the units or volume on your prescription label or from your pharmacy. The FDA warned in August 2026 that compounded vials often differ in concentration, so volumes are not interchangeable between products. Never use a units figure from another vial or an online chart, and ask your prescriber before any dose change.

Compounded Tirzepatide: $120/mo Flat, All-Inclusive

Compounded medications are not FDA-approved and are not covered by insurance. Pricing and availability are subject to change.

Check Your Eligibility

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Pricing, insurance coverage, and compounding regulations described here are subject to change; verify current details with your insurance provider, the manufacturer, or your prescriber before making treatment decisions. Compounded medications are not FDA-approved.

Why trust our experts

Smiling woman with long brown wavy hair wearing a black satin shirt.

April Foster, DO MPH

Reviewer

Board Certified Family Medicine Physician licensed nationwide providing collaborative oversight to NPs, PAs, and RN. Also specializing in telemedicine services nationwide.

Sources

More on this topic